Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial

Craig W Ritchie; Ashley I Bush; Andrew J Mackinnon; Steve Macfarlane; Maree Mastwyk; Lachlan MacGregor; Lyn Kiers; Robert A Cherny; Qiao-Xin Li; Amanda Tammer; Darryl Carrington; Christine Mavros; Irene Volitakis; Michel Xilinas; David Ames; Stephen Davis; Konrad Beyreuther; Rudolph E Tanzi; Colin L Masters

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial

Craig W Ritchie, Ashley I Bush, Andrew J Mackinnon, Steve Macfarlane, Maree Mastwyk, Lachlan MacGregor, Lyn Kiers, Robert A Cherny, Qiao-Xin Li, Amanda Tammer, Darryl Carrington, Christine Mavros, Irene Volitakis, Michel Xilinas, David Ames, Stephen Davis, Konrad Beyreuther, Rudolph E Tanzi, Colin L Masters

Psychiatry Monash Health

Research output: Contribution to journal › Article › Research › peer-review

Original language	English
Pages (from-to)	1685 - 1691
Number of pages	7
Journal	Archives of Neurology
Volume	60
Issue number	12
Publication status	Published - 2003

Cite this

Ritchie, C. W., Bush, A. I., Mackinnon, A. J., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R. A., Li, Q-X., Tammer, A., Carrington, D., Mavros, C., Volitakis, I., Xilinas, M., Ames, D., Davis, S., Beyreuther, K., Tanzi, R. E., & Masters, C. L. (2003). Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial. Archives of Neurology, 60(12), 1685 - 1691.

@article{b691225d0c354ceb8acbd6d3d1ab09e9,

title = "Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial",

author = "Ritchie, {Craig W} and Bush, {Ashley I} and Mackinnon, {Andrew J} and Steve Macfarlane and Maree Mastwyk and Lachlan MacGregor and Lyn Kiers and Cherny, {Robert A} and Qiao-Xin Li and Amanda Tammer and Darryl Carrington and Christine Mavros and Irene Volitakis and Michel Xilinas and David Ames and Stephen Davis and Konrad Beyreuther and Tanzi, {Rudolph E} and Masters, {Colin L}",

year = "2003",

language = "English",

volume = "60",

pages = "1685 -- 1691",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association (AMA)",

number = "12",

}

Ritchie, CW, Bush, AI, Mackinnon, AJ, Macfarlane, S, Mastwyk, M, MacGregor, L, Kiers, L, Cherny, RA, Li, Q-X, Tammer, A, Carrington, D, Mavros, C, Volitakis, I, Xilinas, M, Ames, D, Davis, S, Beyreuther, K, Tanzi, RE & Masters, CL 2003, 'Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial', Archives of Neurology, vol. 60, no. 12, pp. 1685 - 1691.

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial. / Ritchie, Craig W; Bush, Ashley I; Mackinnon, Andrew J et al.

In: Archives of Neurology, Vol. 60, No. 12, 2003, p. 1685 - 1691.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial

AU - Ritchie, Craig W

AU - Bush, Ashley I

AU - Mackinnon, Andrew J

AU - Macfarlane, Steve

AU - Mastwyk, Maree

AU - MacGregor, Lachlan

AU - Kiers, Lyn

AU - Cherny, Robert A

AU - Li, Qiao-Xin

AU - Tammer, Amanda

AU - Carrington, Darryl

AU - Mavros, Christine

AU - Volitakis, Irene

AU - Xilinas, Michel

AU - Ames, David

AU - Davis, Stephen

AU - Beyreuther, Konrad

AU - Tanzi, Rudolph E

AU - Masters, Colin L

PY - 2003

Y1 - 2003

M3 - Article

VL - 60

SP - 1685

EP - 1691

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

IS - 12

ER -